In Vitro Activity of Rifamycin Derivatives against Nontuberculous Mycobacteria, Including Macrolide- and Amikacin-Resistant Clinical Isolates

We evaluated the in vitro activity of rifamycin derivatives, including rifampin, rifapentine, rifaximin, and rifabutin, against clinical nontuberculous mycobacteria (NTM) isolates. Of the rifamycin derivatives, rifabutin showed the lowest MICs against all NTM species, including Mycobacterium avium c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Kim, Dae Hun, Kim, Su-Young, Huh, Hee Jae, Lee, Nam Yong, Koh, Won-Jung, Jhun, Byung Woo
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2021
Matèries:
Susceptibility
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092860/
https://ncbi.nlm.nih.gov/pubmed/33685889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02611-20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars